Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia

OBJECTIVES: Lafutidine is a new H(2)-blocker in India claimed to be more potent and effective than existing H(2)-blockers. Proton pump inhibitors (PPIs), by virtue of their mechanism of action, have greater efficacy than H(2)-blockers in gastric acid suppression. However, clinical trials comparing H...

Descripción completa

Detalles Bibliográficos
Autores principales: Maity, Somnath, Choudhury, Supriyo, Hazra, Avijit, Das, Amal Kanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175885/
https://www.ncbi.nlm.nih.gov/pubmed/25298578
http://dx.doi.org/10.4103/0253-7613.140580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175885/
https://www.ncbi.nlm.nih.gov/pubmed/25298578
http://dx.doi.org/10.4103/0253-7613.140580

Ejemplares similares